Welcome to our dedicated page for Goldman Sachs Group news (Ticker: GS), a resource for investors and traders seeking the latest updates and insights on Goldman Sachs Group stock.
Goldman Sachs Group Inc. (GS) is a global financial services leader specializing in investment banking, asset management, and institutional trading. This page serves as a comprehensive resource for tracking the company's official announcements, strategic initiatives, and market-moving developments.
Investors and professionals will find curated updates on earnings reports, mergers and acquisitions, regulatory filings, and leadership changes. The content collection enables users to monitor GS's responses to market trends, compliance updates, and competitive positioning within global finance.
All press releases and third-party analyses are organized chronologically to simplify trend identification. The resource prioritizes factual reporting on capital allocation strategies, client partnership expansions, and innovation in financial technologies.
Bookmark this page for convenient access to Goldman Sachs' latest developments and check back regularly for real-time updates that matter to your financial decision-making.
Goldman Sachs BDC, Inc. (NYSE: GSBD) has priced an offering of 6,500,000 shares of common stock, aiming to raise approximately
The offering is managed by BofA Securities, Morgan Stanley, and Goldman Sachs & Co. LLC.
Goldman Sachs BDC, Inc. (NYSE: GSBD) announced a planned offering of 6.5 million shares of its common stock, with an option for underwriters to buy an additional 975,000 shares. The offering aims to repay part of its outstanding debt under the revolving credit facility, enabling new investments aligned with its strategies. The completion of the offering depends on market conditions. BofA Securities, Morgan Stanley, and Goldman Sachs & Co. LLC are the joint book-running managers for this offering. Investors are encouraged to review the preliminary prospectus for detailed investment risks.
Bitwise Industries announces an
Goldman Sachs BDC, Inc. (GSBD) reported financial results for Q4 and FY 2022, announcing a net investment income of $0.66 per share, with an adjusted yield of 17.8%. The earnings per share for the quarter was $0.04, while net asset value per share decreased by 2.7% to $14.61. Total investments at fair value were $3.88 billion with a significant majority in senior secured debt (97.6%). A regular dividend of $0.45 per share has been declared for Q1 2023. Notably, net expenses rose to $36.9 million, influenced by increased interest rates.
The Goldman Sachs MLP and Energy Renaissance Fund (NYSE: GER) has announced a quarterly distribution of
Star Mountain Capital has appointed George Mattson as President, a newly created position, to enhance its growth and performance. Mattson, a former partner at Goldman Sachs with 35 years of experience, will also serve on the firm's Investment and Executive Committees. With approximately
Crux has reported significant growth and momentum in 2022, highlighted by $75M in contractual sales commitments and a remarkable annual recurring revenue (ARR) growth exceeding 260%. The company secured $50M in new venture funding, raising its total to $157M, led by Goldman Sachs and Two Sigma. By establishing over 260 partnerships with major data and cloud marketplaces, including Google, Crux's influence in external data technology continues to rise. Their newly introduced External Data Platform aims to democratize data integration, enhancing operational efficiency for clients worldwide.
A joint venture between Goldman Sachs Asset Management and Lane Partners has successfully completed the recapitalization of Southline Phase I, a prominent life science development in South San Francisco. This project, located near public transit options, will consist of two buildings totaling over 715,000 square feet, offering innovative spaces for life science and technology firms. Construction financing has been secured through Square Mile Capital and Bank OZK. The project aims to enhance tenant growth and is positioned within a key life science cluster, reflecting confidence in the Bay Area market.
Shanghai LePure Biotech Co., Ltd. has successfully completed its Series C financing, raising funds from renowned investors including Novo Holdings, General Atlantic, and Goldman Sachs Asset Management. The financing will bolster product innovation, accelerate overseas expansion, and enhance competitiveness in the global market.
Founded in 2011, LePure specializes in single-use bioprocessing solutions for macromolecular drug manufacturing. The recent acquisition of QuaCell Biotechnology enables LePure to expand its product suite, now including cell culture media alongside existing solutions. The company is poised to leverage its first-mover advantage and expertise to respond to market demands.
Goldman Sachs BDC, Inc. (NYSE: GSBD) will announce its financial results for the fourth quarter and fiscal year ended